KFDA to appeal against court's decision on Ferrithin issue.

Published: 2001-02-08 16:49:00

Updated: 2001-02-08 16:49:00

In connection with the recent court decision on the Ferrithin issue, an anti-anemic agent, produced with a horse spleen extract, the KFDA clarified that a strong counter measure including the appeal to the high court should be made in order to justify their earlier determination of these preparat...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK